Bioequivalence Study of Fexofenadine HCl 180 mg + Pseudoephedrine HCl 240 mg ER Tablets of Dr. Reddy's and Allegra D 24 Hour ER Tablets Under Fasting Conditions

• Status: Completed
• Trial end date: 2007-04-01

Summary

The purpose of this study is to

1. Compare and evaluate the single dose, crossover, bioequivalence study of Fexofenadine HCl 180 mg + Pseudoephedrine HCl 240 mg ER Tablets and Allegra-D 24 hr tablets.

2. Monitor the adverse events and ensure the safety of subjects.

• Phase: Phase 1

Details

• Lead Sponsor: Dr. Reddy's Laboratories Limited
• Treatments: Ephedrine; Fexofenadine; Pseudoephedrine; Terfenadine